Public Expectations and Reality of Stem Cell Therapies Translation
By Alexey Bersenev,
Cell Trials
| 12. 07. 2012
Needless to say how much stem cell topic is overhyped today. Just turn on TV or radio and look at local newspaper or Internet –
stem cells are everywhere! The public opinion and perception of stem cell research and therapy is based almost entirely on media reporting. But how close/ far this perception from the reality? Many professionals can speculate that this gap is big. But do we have a data?
Tania Bubela just published a
study, which indicates that
public belief and optimism for stem cell research and translation is largely unjustified and even delusional. This study is very unique and important! We as a field can learn a lot from it!
Our goal is to uncover the nature of the biases in the public discourse on stem cell research that separates fact from fiction. This is the first step to creating better communication strategies among the clinical research community and the public, patients, and policy makers.
They measured public expectation by media coverage and compare it with clinical trials data. Media coverage data were retrieved...
Related Articles
By Annika Inampudi, Science | 08.01.2025
In June, Sara* received a message asking whether she wanted to continue to participate in a massive, multicenter research project led by scientists at Aarhus University in Denmark. The iPsych study, the message said, had sequenced her genetic data from...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Riley Beggin and Jeff Stein, The Washington Post | 08.03.2025
The White House does not plan to require health insurers to provide coverage for in vitro fertilization services, two people with knowledge of internal discussions said, even though the idea was one of President Donald Trump’s key campaign pledges.
Last...
